Bringing the Science of Cost Management to Pharma Artwork
How much does the pharma artwork contribute to the commercial success of a drug? Quite significantly, reveal statistics – both from cost and revenue perspectives. It is estimated that pharmaceutical packaging costs totals up to 70 percent of the cost of the finished product1. When it comes to product recalls, 40 percent of them are due to packaging and labeling errors. And from a regulatory point of view, miniscule errors can prove to be very costly, When you consider that the pharmaceutical packaging market is expected to be worth USD 128 billon by 2025, the enormity of the figures becomes obvious.
A disciplined approach to address challenges
Language, cultural and compliance requirements become important factors for pharmaceutical companies as they expand into global markets. Precision and quality play a big role in guarding both patient safety and the reputation of pharmaceutical companies.
Challenges abound in hitting the sweet spot of pharma artwork management. How can the right coordination and aggregation of information from multiple sources be achieved? How can the right balance between scalability and cost be struck? What are the standardized SOPs that can ensure strict and consistent adherence to GMP and QMS standards? Can the right workflow integration be designed to optimize between turnaround deadlines, regulatory compliance and data security?
Products in the pharmaceutical world face a tough test, and require tremendous support from artwork design in the form of zero errors. This can be achieved through technology-driven robust processes that efficiently integrate the areas of repository management, version control, label regulatory control and authoring. In short, it is all about good project management which combines the best of technology innovation, quality control and workflow processes.
A future-proofed approach to artwork management will involve setting up the right artwork infrastructure and software solution to adhere to compliance, creating a robust knowledge repository that eliminates rework and repetition, and seamlessly integrating R&D and supply chain in the process.
A seamless process – the core to artwork management process
Considering the industry’s heavy investment in packaging, year after year, it is but logical that a customized software solution is looked at to mitigate the error- and defect-prone manual processes that exist today. The right automated solution will minimize defects and delays, and maximize accuracy and speed through the artwork management process.
Collaboration is the name of the game in achieving this end – between product development, packaging, labelling, regulatory affairs, vendors. How can redundant and repeat actions be eliminated? What can be done to bring in visibility across the process chain? These are vital areas that must be addressed.
It starts with an accurate understanding and assessment of current processes and systems – this includes software, applications and tools. The next step is to define the scope and metrics of success criteria. Once this is fixed, it remains to fit the right people, processes and systems.
The ensuing streamlined and SLA-driven artwork management will result in significantly improved quality, and near-zero recalls arising out of artwork errors. Equally powerfully, it will improve branding consistency to add greater credibility to the pharma products. From a compliance perspective, its adherence will save significant penalty costs. Reusable repositories will slash deployment time and costs – both for product launches and for change management.
As complex and challenging it may be, artwork management cannot step away from its ultimate goal of delivering uncompromising quality. Artwork management is absolutely critical to any pharma company’s business strategy. Have the right artwork management partner is thus pivotal to gaining the edge in an intensely competitive market.